298 related articles for article (PubMed ID: 12231540)
1. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
Zhang F; Lu W; Dong Z
Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice.
Cao G; Su J; Lu W; Zhang F; Zhao G; Marteralli D; Dong Z
Cancer Gene Ther; 2001 Jul; 8(7):497-505. PubMed ID: 11498771
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
4. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
6. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ
Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.
Olson MV; Lee J; Zhang F; Wang A; Dong Z
Cancer Gene Ther; 2006 Jul; 13(7):676-85. PubMed ID: 16470211
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
10. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
11. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
12. Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.
Lu W; Fidler IJ; Dong Z
Cancer Res; 1999 Oct; 59(20):5202-8. PubMed ID: 10537298
[TBL] [Abstract][Full Text] [Related]
13. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
Wang B; Xiong Q; Shi Q; Le X; Abbruzzese JL; Xie K
Cancer Res; 2001 Jan; 61(1):71-5. PubMed ID: 11196200
[TBL] [Abstract][Full Text] [Related]
14. Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models.
Qin XQ; Beckham C; Brown JL; Lukashev M; Barsoum J
Mol Ther; 2001 Oct; 4(4):356-64. PubMed ID: 11592839
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
17. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.
Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M
Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726
[TBL] [Abstract][Full Text] [Related]
20. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.
Kim SJ; Uehara H; Karashima T; Shepherd DL; Killion JJ; Fidler IJ
Clin Cancer Res; 2003 Mar; 9(3):1200-10. PubMed ID: 12631626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
